Nykode Therapeutics - Grant of share options
Nykode Therapeutics ASA (NYKD) · publisert 30. januar 2026 kl. 22:44 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Barbara Krebs-Pohl | Styreleder | Annet Tildeling | 300 000 | 0 NOK | 30. januar 2026 | NO0010714785 | Outside of trading venue |
| John Beadle | Styremedlem | Annet Tildeling | 150 000 | 0 NOK | 30. januar 2026 | NO0010714785 | Outside of trading venue |
| Susanne Stuffers | Styremedlem | Annet Tildeling | 150 000 | 0 NOK | 30. januar 2026 | NO0010714785 | Outside of trading venue |
Vedlegg
- Attachment Options 300126.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, January 30, 2026 - Reference is made to the Extraordinary General Meeting (EGM) in Nykode Therapeutics ASA held on January 21, 2026, where the grant of share options to certain members of the Board was approved. A total of 600,000 share options with a strike price of NOK 7.00 per share have been granted in accordance with the terms set out in the minutes from the EGM.
Please see further details in attached document